Qualified Person for Pharmacovigilance

EEA-Compliant Pharmacovigilance Systems

Marketing Authorization Holders (MAH) of medicinal products authorized for marketing in the European Economic Area (EEA) have a legal responsibility to establish a robust PV system. Central to this obligation is the appointment of a Qualified Person for Pharmacovigilance (QPPV) and, in some cases, a Local Responsible Person (LRP) or Local Person Responsible for PV (LPPV) support. This requirement ensures that safety data is continuously monitored and reported according to strict regulatory timelines, thereby maintaining patient safety. The European Medicines Agency (EMA) requires that this system be documented thoroughly within a Pharmacovigilance System Master File (PSMF), which must be accessible at all times to regulatory inspectors.
The QPPV serves as the cornerstone of an MAH's pharmacovigilance system in the EU. Their responsibilities encompass a wide range of critical tasks, including establishing and maintaining the MAH's PV system, monitoring product safety, and overseeing the PV system's functioning and quality. The QPPV must reside and operate within a member state of the EEA.
In addition to the QPPV, certain EEA countries may require the appointment of an LRP or Local QPPV for Pharmacovigilance, especially in the context of the UK post-Brexit. These local personnel are tasked with specific local-level responsibilities, including collecting, processing, and submitting Individual Case Safety Reports (ICSR) at the national level, and acting as a liaison between the MAH and local Regulatory authorities.

Core Responsibilities of the QPPV

The QPPV must be 24/7 available as the single point of contact for Regulatory authorities on PV related matters. This ensures that the PSMF is always up-to-date and accessible to authorities upon request. They are responsible for monitoring product safety and emerging safety concerns proactively, ensuring that all data is analyzed meticulously to detect potential hazards early. The QPPV must also provide input into the preparation of regulatory submissions, such as Risk Management Plans (RMP) and Periodic Safety Update Reports (PSUR), ensuring that safety information is accurately reflected and consistent.
LRPs must usually be resident of the country where their services are required and possess fluency in the local language to interact effectively with national agencies. They are also involved in the implementation of additional Risk Minimization Measures (aRMM) and local submissions of other PV documents, ensuring complete compliance with regional requirements.

Proregulations' Specialized QPPV and LRP Support Solutions

Proregulations offers a comprehensive suite of QPPV Services tailored to meet the diverse needs of MAHs operating in the pharmaceutical industry. Our solutions ensure that all legal obligations are met while enhancing the efficiency of your safety operations. Our services include:

• QPPV services
  Proregulations provides QPPV services to ensure robust QPPV coverage across the region, tailored to specific MAH requirements within the EEA.
• Local support
  Leveraging an extensive affiliate network, we provide LPPV support for most EU countries, ensuring compliance with local PV requirements and regulations.
• Affiliate network
  An extensive affiliate network spanning the globe enables us to provide tailored QPPV services, LPPV, and LRP solutions not only within the EU but also in regions outside the EEA.
• Consulting support
  Our team assists in the preparation and maintenance of the PSMF, ensuring it is ready for regulatory inspections and audits.

If you need to establish a compliant PV system or require local safety representation in the EEA, please contact us to leverage our expert QPPV and LRP solutions.